Literature DB >> 2683071

Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

C E Hart1, C Y Ou, J C Galphin, J Moore, L T Bacheler, J J Wasmuth, S R Petteway, G Schochetman.   

Abstract

Host cell factors act together with regulatory genes of the human immunodeficiency virus (HIV) to control virus production. Human-Chinese hamster ovary hybrid cell clones were used to probe for human chromosomes involved in regulating HIV gene expression. DNA transfection experiments showed that 4 of 18 clones had high levels of HIV gene expression measured by both extracellular virus production and transactivation of the HIV long terminal repeat in the presence of the trans-activator (tat) gene. Karyotype analyses revealed a 94% concordance (17/18) between human chromosome 12 and HIV gene expression. Other chromosomes had an 11 to 72% concordance with virus production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683071     DOI: 10.1126/science.2683071

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

1.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein.

Authors:  P J Dillon; J Lenz; C A Rosen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.

Authors:  Jinglin Sun; Timothy Soos; Vineet N Kewalramani; Kristin Osiecki; Jian Hua Zheng; Laurie Falkin; Laura Santambrogio; Dan R Littman; Harris Goldstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter.

Authors:  K Desai; P M Loewenstein; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.

Authors:  Naomi Tsurutani; Jiro Yasuda; Naoki Yamamoto; Byung-Il Choi; Motohiko Kadoki; Yoichiro Iwakura
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.

Authors:  L Yu; Z Zhang; P M Loewenstein; K Desai; Q Tang; D Mao; J S Symington; M Green
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Cloning and characterization of a second human NRAMP gene on chromosome 12q13.

Authors:  S Vidal; A M Belouchi; M Cellier; B Beatty; P Gros
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

10.  Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.

Authors:  R F Speck; M L Penn; J Wimmer; U Esser; B F Hague; T J Kindt; R E Atchison; M A Goldsmith
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.